monkey pox treatment market growth, monkey pox treatment market top players, monkey pox treatment market research, monkey pox treatment market demand, monkey pox treatment market outlook, monkey pox treatment market scope
What are the latest figures on the monkey pox treatment market’s size and projected CAGR?
The monkey pox treatment market size has grown rapidly in recent years. It will grow from $0.09 billion in 2024 to $0.1 billion in 2025 at a compound annual growth rate (CAGR) of 13.6%. The growth in the historic period can be attributed to outbreaks in endemic regions, zoonotic transmission awareness, smallpox eradication legacy, public health initiatives, emergence of human cases.
The monkey pox treatment market size is expected to see rapid growth in the next few years. It will grow to $0.17 billion in 2029 at a compound annual growth rate (CAGR) of 13.3%. The growth in the forecast period can be attributed to globalization and travel, government funding and support, biotech and pharmaceutical investment, public health surveillance, and regulatory approvals. Major trends in the forecast period include antiviral drug development, use of smallpox vaccines, monoclonal antibodies, combination therapies, and long-term immunity research.
Get Your Free Sample of The Global Monkey Pox Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18818&type=smp
What are the key forces behind the monkey pox treatment market’s growth in recent years?
The increasing prevalence of zoonotic infection is expected to propel the growth of the monkeypox treatment market going forward. A zoonotic infection is a disease that is transmitted from animals to humans through direct contact with contaminated environments or vectors. With increased human-animal interaction by bringing people and animals into closer contact raises zoonotic infection risks. Moreover, climate change worsens this risk by expanding disease vector ranges and introducing pathogens to new areas. Monkeypox treatments are used to manage zoonotic mpox by targeting the virus and alleviating symptoms in both humans and potentially infected animals. For instance, in August 2024, according to a report published by the UK Health Security Agency, a UK-based government agency, there were 3,732 confirmed mpox cases in the UK, rising by 21 more in 2023 with 3753 cases. Therefore, the increasing prevalence of zoonotic infection drives the monkeypox treatment market.
What are the major segments of the monkey pox treatment market?
The monkey pox treatment market covered in this report is segmented –
1) By Treatment Type: Prophylactic Vaccines, Therapeutics
2) By Dosage Forms: Solid, Liquid, Semi Solid
3) By Route Of Administration: Oral, Topical, Parenteral
4) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Pharmacies
Subsegments:
1) By Prophylactic Vaccines: Vaccinia-Based Vaccines, Modified Vaccinia Ankara (MVA) Vaccines, Other Vaccines (Recombinant Vaccines)
2) By Therapeutics: Antiviral Agents (Tecovirimat, Brincidofovir), Immune Modulators, Supportive Care Treatments
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/monkey-pox-treatment-global-market-report
Which companies dominate the monkey pox treatment market?
Major companies operating in the monkey pox treatment market are Roche Holding AG, Merck & Co. Inc., Sanofi S.A., Gilead Sciences Inc., BioNTech SE, Moderna Inc., Quest Diagnostics Incorporated, Novavax Inc., Laboratory Corporation of America Holdings, Emergent BioSolutions Inc., Bavarian Nordic A/S, Aegis Sciences Corporation, Daan Gene Co. Ltd., Sansure Biotech Inc., SIGA Technologies Inc., Elabscience Biotechnology Inc., Mayo Clinic Laboratories, Tonix Pharmaceuticals Holding Corp., Altona Diagnostics GmbH, Lansion Biotechnology Co. Ltd., Goldsite Diagnostics Inc., Chimerix Inc., Emcure Pharmaceuticals Ltd., VBI Vaccines Inc
What major trends will shape the monkey pox treatment market during the forecast period?
Major companies operating in the monkeypox treatment market focus on remote monitoring and teletherapy solutions such as virtual care to enhance accessibility, streamline patient management, and improve overall treatment outcomes. Virtual care for monkeypox treatment provides remote medical consultations, symptom evaluation, and management strategies to individuals at risk or infected, facilitating access to care while reducing the need for in-person visits. For instance, in August 2022, Folx Health, a US-based healthcare company, introduced Monkeypox Care, virtual primary care services for individuals at risk of or affected by monkeypox. It employs a comprehensive strategy that includes education, counseling, symptom evaluation, and referrals. The initiative is designed to reach individuals in care deserts—areas with limited access to healthcare, ensuring that quality information and referrals are accessible to all, regardless of location.
What are the key regional dynamics of the monkey pox treatment market, and which region leads in market share?
North America was the largest region in the monkey pox treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Monkey Pox Treatment Market Report 2025 Offer?
The monkey pox treatment market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Monkeypox treatment refers to the medical interventions and therapies used to manage and alleviate the symptoms of monkeypox, a viral disease caused by the monkeypox virus. It encompasses a range of therapeutic and supportive approaches aimed at reducing the severity of the disease and improving patient outcomes.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=18818
About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
